Announcement on Voluntary Disclosure of Obtaining US FDA Approval Number for the Company's Enzalutamide Tablets

About this update from Sinotherapeutics, Inc. Class A

Announcement on Voluntary Disclosure of Obtaining US FDA Approval Number for the Company's Enzalutamide TabletsThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sinotherapeutics, Inc. Class A